Exercise & FitnessClinical TrialPaywall

Combining NR Supplements With Exercise May Finally Unlock NAD+ Benefits in Humans

A completed Maastricht University trial tests whether pairing NR supplementation with exercise can boost NAD+ levels and reverse metabolic dysfunction in overweight adults.

Saturday, May 30, 2026 1 views
Published in Exercise & Cardiovascular Aging Trials
A middle-aged person on a stationary bike in a clinical exercise lab, with supplement capsules and a blood sample vial on a tray in the foreground

Summary

Animal studies have shown nicotinamide riboside (NR) can raise NAD+ levels and improve metabolic health, but human trials have repeatedly failed to replicate these results. Researchers at Maastricht University Medical Center proposed a key reason: NAD+ levels need to be genuinely depleted before NR supplementation works. Exercise naturally drains NAD+, potentially creating the deficit needed for NR to shine. This completed trial enrolled 30 overweight or obese participants and combined NR supplementation with structured exercise to test whether this combination could improve mitochondrial function, exercise capacity, and insulin sensitivity. The study targets conditions — obesity, type 2 diabetes, and age-related metabolic decline — that affect hundreds of millions worldwide. Results from this novel combination approach could reshape how NAD+ precursors are used clinically.

Detailed Summary

NAD+ is a critical coenzyme in cellular energy metabolism, and its decline with age is now considered a hallmark of metabolic deterioration. Low NAD+ bioavailability has been documented in aging humans, obese individuals, and diabetic animal models, making NAD+ restoration a high-priority target in longevity research. Nicotinamide riboside (NR), a natural vitamin B3 precursor, has emerged as one of the most popular strategies to elevate cellular NAD+ levels.

Despite compelling preclinical evidence, human clinical trials supplementing with NR alone have consistently failed to improve skeletal muscle mitochondrial function, exercise capacity, or insulin sensitivity. This translational gap has puzzled researchers and raised questions about whether the human metabolic environment differs fundamentally from animal models — or whether the right context for NR to work simply hasn't been tested yet.

This trial from Maastricht University Medical Center tested a novel hypothesis: that NAD+ must be in a depleted state for NR supplementation to exert measurable effects. Exercise is a potent physiological stressor that draws heavily on NAD+ stores, theoretically creating the deficit needed for supplemental NR to be meaningfully incorporated and utilized. Thirty overweight or obese adults were enrolled in this completed phase NA trial combining NR (Niagen) with structured exercise.

The primary conditions of interest — overweight, obesity, aging, and type 2 diabetes — are precisely the populations where NAD+ deficits are most pronounced, making this cohort highly relevant. The study ran from August 2021 to December 2022, with full results not yet publicly reported in the available abstract.

If the exercise-plus-NR combination proves effective, it would validate a fundamentally different model for NAD+ supplementation: context-dependent efficacy rather than universal supplementation. This could refocus clinical protocols toward combined lifestyle and nutraceutical interventions rather than supplements alone, with major implications for metabolic health management in aging populations.

Key Findings

  • NR supplementation alone has failed to improve mitochondrial function or insulin sensitivity in prior human trials.
  • Exercise may deplete NAD+ sufficiently to create the deficit needed for NR supplementation to work.
  • Trial combined NR (Niagen) with exercise in 30 overweight/obese adults to test this combination hypothesis.
  • Target conditions — obesity, type 2 diabetes, aging — are those with the most pronounced NAD+ deficits.
  • Results from this completed trial could redefine clinical protocols for NAD+ precursor supplementation.

Methodology

This was a completed interventional trial (Phase NA) enrolling 30 overweight or obese adults at Maastricht University Medical Center, combining NR supplementation (Niagen) with structured exercise. The study ran approximately 16 months from August 2021 to December 2022. Full methodology details including randomization, blinding, dosing protocol, and specific outcome measures are not available from the abstract alone.

Study Limitations

This summary is based on the abstract only; full methodology, primary endpoints, outcome data, and statistical results are not available, significantly limiting interpretation. The trial enrolled only 30 participants, which may limit statistical power to detect modest effects. Phase NA designation and absence of published results mean clinical conclusions cannot yet be drawn from this registration alone.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.